CAS number: 127-31-1

General information about the Fludrocortisone Base active pharmaceutical ingredient

Fludrocortisone Base as active pharmaceutical ingredient (API) is a corticosteroid and acts as a powerful mineralocorticoid, along with some additional but comparatively very weak glucocorticoid activity. Fludrocortisone Base is used to treat adrenocortical insufficiency, postural hypotension, and adrenal hyperplasia. Fludrocortisone Base comes as in the form of oral tablets.

Axplora manufactures Fludrocortisone Base API

Fludrocortisone Base API is manufactured in cGMP by Axplora via chemical synthesis from early stage starting material. Fludrocortisone Base API is produced by Farmabios, our EUGMP, USFDA and PMDA approved manufacturing site with legal seat in Gropello Cairoli, Italy. Farmabios’ expertise is to make and handle with steroids, niche hormones, and highly potent active pharmaceutical ingredient (HPAPI), including cytotoxic drugs. Fludrocortisone Base API is commercially available as micronized grade specifically designed around various formulation requirements. Tailor-made packaging solutions are available upon request. Feel free to contact us if you need any additional information about Fludrocortisone Base API.
  • Therapeutic area Anti-Inflammatory
  • Monograph INTERNAL
  • Available grade Micronized
  • Regulatory documentation EU DMF
  • Produced in GRO